MediPharm Labs executive management team will also host a conference call and webcast on Wednesday, May 14, 2025, at 10:00 a.m. (Eastern time) to discuss the Company's financial results.

TORONTO, Aug. 13, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based ...

MediPharm Labs and Shelter Cannabis Brands have terminated their royalty agreement with a one-time cash payment. Agreement includes the elimination of ongoing royalty payments, for a one-time lump sum ...

BARRIE, Ontario, Oct. 23, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (the “Company”) a global leader in specialized ...

David Pidduck, CEO, MediPharm Labs commented, "We are proud of our focus on margins, cost reductions and profitability. Now, our strong balance sheet and improving profitability favourably positions ...

Avicanna Inc. AVCNF AVCN (FSE:0NN) announced the extension of its existing strategic manufacturing agreement with Medipharm Labs Inc. MEDIF for the commercialization of Avicanna’s proprietary ...

TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (“MediPharm”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is ...

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced that David Pidduck will ...

TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a ...

MediPharm Labs Corp. LABS MEDIF MLZ reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of around C$1 million ...